Upon withdrawal of interleukin-3 (IL-3) from human factordependent erythroleukemic cell line TF-1, bcl-2 mRNA and protein levels decrease within 8 t o 24 hours. Accompanying this decrease is the onset of apoptosis as determined by flow cytometric analysis of DNA degradation. By 8 t o 18 hours of deprivation approximately 70% t o 8090 of the cells have entered apoptosis. Downregulation of protein kinase (PK) by a 24-hour incubation in 100 nmol/L 12-0-tetradecanoyl-phorbol-13-acetate (TPA) in the presence of IL-3 dramatically reduced bcl-2 mRNA levels, and induced apoptosis in the presence of IL-3. We have also found that even in the presence of IL-3, t w o inhibitors of PKC, light-activated calphostin and H-7, substantially reduced the levels of bcl-2 mRNA between 8 and 24 hours as measured by a semiquantitative reverse transcriptase/polymerase chain reaction assay method; however, the cyclic nucleotide-depen-UMAN INTERLEUKIN-3 (huIL-3) is a pluripotent multi-lineage hematopoietic colony-stimulating factor (CSF) that is secreted by activated T cells and is part of the communication system linking the immune system to the hematopoietic system.',' IL-3 is unique among the CSFs because it can regulate the development of blood cell progenitors in all the hematopoietic lineages. This regulation is manifest as the capacity of this CSF to ensure the proliferation and survival of hematopoietic progenitor cells. The continued survival of IL-3-dependent cells is accomplished through the suppression of an active program of cell death that is induced when the cells are factor d e p r i~e d .~.~ Cells undergoing this programmed cell death exhibit the features of apoptosis including a characteristic endonuclease-mediated cleavage of DNA into 200-bp size m~ltimers.'.~ Expression of the bel-2 proto-oncogene is associated with the suppression of apoptosis in hemopoietic cells both in vivo and in vitro.'" The 26-kD product of this gene is localized at a number of intracellular membranes with a predominant localization in mitochondria.*"' Although it is not clear precisely how the bel-2 protein suppresses apoptosis, recent evidence suggests that bel-2 may regulate an antioxidant pathway at sites of free radical generation." Studies in murine IL-3-dependent FDCP-l cells have shown that the The publication costs of this article were defrayed in part by page charge payment. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. section 1734 solely to indicate this fact.
UMAN INTERLEUKIN-3 (huIL-3) is a pluripotent
multi-lineage hematopoietic colony-stimulating factor (CSF) that is secreted by activated T cells and is part of the communication system linking the immune system to the hematopoietic system.',' IL-3 is unique among the CSFs because it can regulate the development of blood cell progenitors in all the hematopoietic lineages. This regulation is manifest as the capacity of this CSF to ensure the proliferation and survival of hematopoietic progenitor cells. The continued survival of IL-3-dependent cells is accomplished through the suppression of an active program of cell death that is induced when the cells are factor d e p r i~e d .~.~ Cells undergoing this programmed cell death exhibit the features of apoptosis including a characteristic endonuclease-mediated cleavage of DNA into 200-bp size m~ltimers.'.~ Expression of the bel-2 proto-oncogene is associated with the suppression of apoptosis in hemopoietic cells both in vivo and in vitro.'" The 26-kD product of this gene is localized at a number of intracellular membranes with a predominant localization in mitochondria.*"' Although it is not clear precisely how the bel-2 protein suppresses apoptosis, recent evidence suggests that bel-2 may regulate an antioxidant pathway at sites of free radical generation." Studies in murine IL-3-dependent FDCP-l cells have shown that the dent PK inhibitor HA 1004, that is a structural analog of H-7 but a poor inhibitor of PKC, did not reduce bcl-2 levels in the presence of IL-3. This decrease in bcl-2 mRNA was accompanied by a decline in bcl-2 protein levels by 8 t o 24 hours after addition of light-activated calphostin. In addition t o interfering with the maintenance of bcl-2 mRNA levels, inhibition of PKC with H-7 inhibited the induction of bcl-2 mRNA in factor-deprived TF-1 cells restimulated with IL-3. The cyclic nucleotide-dependent PK inhibitor HA 1004 did not inhibit IL-3-induced bcl-2mRNA. Studies with actinomycin D showed that transcription plays a major role in maintaining bcl-2 levels in TF-1 cells, and it is therefore likely that IL-3 plays a role in maintaining bcl-2 transcription through activation of PKC in these cells. bel-2 gene is constitutively expressed in the presence of IL-3, and bel-2 gene expression decreases when the cells are deprived of IL-3 and commencing apoptosis." Transfection of IL-3-dependent cells with plasmids capable of overexpressing the bel-2 gene extends cell survival time in the absence of IL-3." Thus, the regulation of bel-2 expression appears to be an important component in the suppression of apoptosis and maintenance of cell survival in hematopoietic cells.
The biochemical regulation of bel-2 expression through cytokine-mediated pathways is poorly understood; however, recent work on the regulation of bel-2 expression through the IL-2 and IL-3 receptors in murine myeloid cells indicates a role for tyrosine kinases in maintaining this gene expression.I4 The downstream effectors of tyrosine phosphorylation in regulating bel-2 expression are uncharacterized. Recent studies from our laboratory indicate that a phosphatidylcholine specific phospholipase C and protein kinase C (PKC) are activated downstream of huIL-3-induced tyrosine phosphorylation in M07E cells and NIH 3T3 cells transfected with the huIL-3 receptor subunits."," Although it has been shown that IL-3 and granulocyte-macrophage CSF (GM-CSF) modulate c-jun expression through PKC, other genes modulated by IL-3-induced PKC activation remain to be el~cidated.".'~ Interestingly, in rat thymocytes and huIL-3-dependent M07E cells it has been reported that PKC may play a role in suppressing apoptosi~.l~.~" If bcl-2 expression is central to suppressing apoptosis in both murine and huIL-3-dependent cells, then PKC might induce suppression of apoptosis in part by regulating the expression of the bel-2 gene in these cells. Therefore, we have investigated the role of PKC in modulating bel-2 expression through the IL-3 receptor in huIL-3-dependent TF-l cells.
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obtained from Biosource International (Camarillo, CA). TPA was dissolved in DMSO and added to the cell cultures such that the DMSO concentration was 0.1 % or less. This concentration of DMSO did not alter gene expression compared with untreated control cell cultures.
Cell culture. The human L-3-dependent erythroleukemia cell line T F -1 was maintained in RPM1 1640 medium supplemented with penicillidstreptomycin, 10% fetal bovine serum, and 10% A5637 bladder carcinoma cell conditioned medium (American Type Culture Collection, Rockville, MD). The A5637 conditioned medium provides a source of huIL-3 to propagate stock cultures. Twenty-four hours before beginning experiments, cells were cultured in fresh medium containing 10% serum and 10 ng/mL purified recombinant huIL-3. Stock cultures were passaged at or before attaining a density of 5 X 10s cells/mL. DNA fragmentation analysis. The technique used was adopted from that of Rajotte et al." Briefly, cultures of cells were incubated under the desired conditions, harvested, and counted. Equal numbers of cells were broken in lysis buffer containing 50 mmol/L TRIS pH 8.0, 10 mmoW EDTA 0.5% Sarkosyl, and 0.5 mg/mL proteinase K. After a l-hour incubation at 5 0 T , RNase A was added to a concentration of 0.15 mg/mL. After a further l-hour incubation at 5WC, 10 pL of a solution of 10 mmol/L EDTA pH 8.0 containing 1% low-melting agarose was added. The samples were heated at 70°C before loading on a l .2% agarose gel containing 0.1 pg/mL ethidium bromide. Electrophoresis was conducted in a buffer of 90 mmol/L TRIS, 90 mmoW borate, 2 mmol/L EDTA for 15 hours at
Flow cytometric analysis of apoptotic cells. Apoptotic cells were fluorescently stained using the Apoptag Kit from Oncogene Sciences (Manhassett, NY). Flow cytometric analysis was performed using a Facscan flow Cytometer (Becton Dickinson Corp). DNA was stained with propidium iodide for red fluorescence, and free 3' OH ends, resulting from apoptotic endonuclease degradation, were labeled with digoxigenin-dUTP and stained with fluorescein-labeled antibody against digoxigenin.
Immunoblotting. Cells were collected and washed three times in cold (4°C) phosphate-buffered saline (PBS) without Ca" and MgZt. For immunoblotting of bcl-2 protein, washed cells were then resuspended in 200 pL of lysis buffer containing 10 mmoVL sodium phosphate pH 7.4,O. 15 mmoVL NaCI, 6 mmoVL phenylmethylsulfonyl fluoride (PMSF), 3% Triton X-100 (Sigma Chemical CO, St Louis, MO), 5 mmoVL EDTA, 150 mmoVL benzamidine, and 1 U/ mL of aprotinin. Lysate supernatants were prepared for protein analysis by repeated freezehhawing and high-speed centrifugation, and 100 pg of protein was used for immunoblot analysis as described previously.2' Immunologic detection of bcl-2 was performed with a previously described polyclonal antibody." Immunoreactivity was detected with peroxidase-conjugated second antibody and chemiluminescence (ECL; Amersham Corp. Chicago, IL). Lysates for PKC immunoblot analysis were prepared by hypotonic lysis of cells in a buffer composed in 1 mmoVL NaHC03, 5 mmoVL MgCI2, 100 pmoVL PMSF, pH 7.5. Nuclei and unlysed cells were sedimented for separation of membranes from cytosol by centrifugation at 500s X 5 minutes at 4°C. The postnuclear supernatant was centrifuged at 100,ooOg for 30 minutes at 4°C. The membrane pellet was then resuspended in lysis buffer and the protein content of the membranes and cytosol was determined. Protein (100 to 180 pg) was solubilized by boiling for 5 minutes in 2X Laemmli's buffer containing 10 mmoVL P-mercaptoethanol, and was resolved in a 10% sodium dodecyl sulfate (SDS) polyacrylamide gel under reducing conditions. Resolved proteins were transferred to nitrocellulose membranes by electrophoretic transfer. After transfer, membranes were blocked with 5% nonfat evaporated milk in 10 mmol/L TRIS pH 7.5, 0.15 mmol/L NaCI, and 0.05% Tween-20. Immunologic detection of PKC isoforms was with isoform-specific antibodies obtained from GIBCO Life Technologies Inc (Grand Island, NY). Immunoreactivity was detected with peroxidase-conjugated second antibody and chemiluminescence (ECL; Amersham Corp).
RNA isolation. Total cellular RNA was isolated by the method of Chomzynski and Sacchi." The integrity of the isolated RNA was routinely assessed by agarose gel electrophoresis and staining with ethidium bromide. Only samples with intact ribosomal RNA bands were used for further analysis.
Reverse transeriptase/polymerase chain reaction (RT/PCR) semiquantitative analysis of bcl-2 mRNA expression. We used a modification of published methods for quantitative PCR analysis to obtain a semiquantitative estimate of changes in bel-2 mRNA.23. 24 Briefly simultaneous amplification of both bel-2 and glyceraldehyde 3 phosphate-dehydrogense (GAPDH) mRNAs was performed. GAPDH is constitutively expressed and unaffected by changes in PKC or cyclic nucleotide-dependent kinase activity. Therefore, it serves as an internal control for differences between samples in RT or PCR efficiency. The bcl-2 primers used spanned the exon l-exon 2 regions of the human gene and would detect the major 8.5-and 5.5-kb ~R N A s . '~ In the sense orientation the oligonucleotide had the sequence 5'GGA TCC AGG ATA ACG GAG GCT GG3' (nucleotides 2021-42) and in the antisense orientation 5'GGC ATG 'ITG ACT TCA C l T G3' (nucleotides 2169-90).25 An internal probe 5' CCA CCA GGG CCA AAC TGA-GC3' (nucleotides 21 was also synthesized to verify the authenticity of the bcl-2 PCR products by Southern blotting." The GAPDH primers used were in the sense direction 5'TGA AGG TCG GAG TCA ACG GAT TTG GT3' and in the antisense direction 5'CAT GTG GGC CAT GAG GTC CAC CAC3'. All oligonucleotides were synthesized on an automated DNA Synthesizer using phosphoramidite chemistry (Applied Biosystems, Foster City, CA). We used an input total RNA concentration of 700 ng that yielded optimal product on the linear portion of the RT/PCR amplification curve. RNA was reverse transcribed with random hexanucleotides and Moloney murine leukemia virus reverse transcriptase using previously described conditions and a Perkin-Elmer R T R R kit (Perkin-Elmer Cetus, Branchburg, NJ).23.M The reaction mixture was heated at 99°C for 1 minute to inactivate the RT. DNA product was amplified with Taq polymerase using an automated thermal cycler assuring the same heating and cooling conditions for each sample. Samples were held at 94°C for 1 minute, 60°C for 1.5 minutes, and 72°C for 1.5 minutes. The thermal cycle was repeated 30 times. With this cycle number we found that both the GAPDH and bel-2 DNA products were on the exponential part of the amplification curve. As suggested by Kinoshita et al, 24 we delayed the addition of the GAPDH primers (0.15 pmol/L) until three cycles after the start of the PCR amplification with the bcl-2 primers (0.30 pmoU L). This assured that the GAPDH and bel-2 primers did not interfere and allowed us to obtain a greater bcl-2 signal than could be obtained with simultaneous addition of both sets of primers. Using these conditions both GAPDH and bcl-2 DNA products are proportional to input RNA, on the linear part of the amplification curve, and can be detected by ethidium bromide staining after electrophoretic separation in a 2% agarose gel. Thus, GAPDH levels and bel-2 levels can be directly compared, and are proportional to their abundance in the input RNA.
Scanning densitometry. For quantitative analysis, photographic negatives of gels were scanned with a HP Scan Jet-csm digitizing scanner (Hewlett Packard CO, North Hollywood, CA). The digitized images were quantitated with the One-D Gel Scan program from Scanalytics Inc (Billerica, MA). At appropriate times after deprivation, RNA was isolated for cDNA synthesis. cDNA was amplified using primers for bcl-2 and GAPDH. Amplified DNA was analyzed by agarose gel electrophoresis and ethidium bromide staining. (B) Quantitation of PCR products by scanning densitometry. The ethidium bromide-stained gel was analyzed by scanning densitometry and each bcl-2value was divided by its companion GAPDH intensity t o correct for variations in amplification or loading. The final value presented is a percentage of the value calculated for IL-3 alone (10OYol at each time point. The experiment was repeated twice with similar results each time. (C) Cells were deprived of IL-3 as described in (A). Cellular protein was isolated and analyzed for bcl-.?protein by SDS-polyacrylamide gel electrophoresis and immunoblotting with a polyclonal antibody against bcl-2 and developed with chemiluminescence. Equal amounts of protein IL-3 deprivation approximately 70% of the cells enter apoptosis (Fig l) . At 18 hours after deprivation only 70% to 80% of the cells are apoptotic, but there is an increased intensity of staining of free 3'OH ends in the DNA. Thus, it appears from the fluorescent analysis of apoptotic DNA that most of the cells have entered apoptosis by 8 hours, and between 8 and 18 hours there is an increase in green fluorescence indicating further apoptotic degradation of the DNA. Thus, at 18 hours after deprivation 20% to 30% of the cells remain viable.
RESULTS

Suppression of apoptosis and maintenance
Analysis of bel-2 mRNA levels by semiquantitative RT/ PCR in similarly deprived cells showed that the hcl-2 mRNA levels are also significantly decreased with kinetics similar to those of the appearance of apoptotic DNA fragments (Fig  2A) . The GAPDH mRNA levels remain constant during this 1 8-hour period. Southern blotting of the putative bel-2 PCR product and probing with the internal oligonucleotide described under Materials and Methods verified that the product was bel-2 (data not shown). Densitometric analysis of the gel shown in Fig 2 revealed that by 8 hours of IL-3 deprivation the bcl mRNA levels had decreased to 35% to 40% of control value (Fig 2B) . Immunoblot analysis of bel-2 protein levels also showed that protein levels decreased similarly to mRNA after withdrawal of IL-3 (Fig 2C) . A decrease in bel-2 protein from control levels was also observed within 8 to 24 hours after withdrawal of IL-3. AIthough the bel-2 protein is reported to have a half-life of 10 to 12 hours," Nunez et all3 have shown that in factor-deprived 32D cells bel-2 levels decrease dramatically by 6 hours after deprivation and are almost undetectable by 12 hours.I3 Our data are consistent with these findings, and suggest a possible shorter protein half-life in apoptotic cells. The residual 1x1-2 mRNA and protein observed after 18 to 24 hours of IL-3 deprivation probably represent bel-2 gene expression in the 20% to 30% of the cells that have not entered apoptosis and perhaps residual bel-2 in the apoptotic cells.
Downregulation of PKC with pllorbol ester decrerrses bcl-2 mRNA levels. To begin examining the role of PKC in the IL-3 signal transduction cascade that maintains bel-2 expression in TF-I cells, we downregulated the enzyme by incubation of the cells with 100 nmol/L TPA for 24 hours in the presence of IL-3 (10 ng/mL). Previous work has shown that IL-3 receptors continue to bind ligand after extended incubation in phorbol ester.'* We have also verified that TPA-treated TF-I cells continue to bind ['9] IL-3 similarly to control cells using previously described methods (data not shown).'" Lysates from cells incubated in IL-3 alone or TPA plus IL-3 for 24 hours were fractionated to determine the presence of PKC in membranes and cytosol. Protein from these fractions was resolved by polyacrylamide gel electrophoresis and immunoblotted. Probing with a pan PKC antibody, that recognizes all the isoforms, showed that in the cells cultured in IL-3 alone the majority of the enzyme was localized on the membranes and only a small amount was detectable in the cytosol; however, in those cells cultured in IL-3 plus 100 nmol/L TPA for 24 hours there was a large decrease in the membrane-bound PKC (Fig 3) . The epsilon isoform of PKC has recently been specifically implicated in the mechanism of IL"3M-CSF signal transduction in experiments using isoform-specific antisense oligonucleotides."' Therefore, we also probed specifically for the presence of this isoform. Again we found that in the IL-3-cultured cells the epsilon isoform is membrane bound and none was detectable in the cytosol. However, in the TPAtreated cells no epsilon isoform was detectable bound to membranes after 24 hours. The TPA solvent (0.1% DMSO) had no effect on membrane-bound PKC when compared with cell incubated only in IL-3 (data not shown). Analysis of bel-2 mRNA in TF-I cells after 24-hour incubation in 100 nmol/L TPA is shown in Fig 4A. Preliminary experiments showed that the levels of bel-2 mRNA are the same in untreated and solvent control (0.1% DMSO)-treated cells cultured in IL-3 (data not shown). However, cells incubated in IL-3 + 100 nmol/L TPA showed little detectable bel-2 mRNA compared with solvent vehicle control-treated cultures. Thus. the downregulation of PKC correlates with the loss of bel-2 mRNA in cells cultured in the presence of IL-3. The downregdation of PKC by extended incubation of cells in TPA also induced apoptosis in TF-I cells even in the presence of IL-3 (Fig 4B) . In fact, downregulation of PKC further enhanced apoptosis in cells deprived of IL-3 ( Fig 4B) .
Efects qf calpkostin, H-7, and HA 1004 on bcl-2 mRNA and protein levels. Although phorbol ester effectively downregulated PKC in these cells. it could also have other effects on cellular metabolism that might contribute to the decrease in bel-2 mRNA levels. Therefore, to confirm a role for PKC in bel-2 regulation we performed experiments with relatively specific. but structurally unrelated, biochemical 
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inhibitors of PKC:calphostin and H-7. Calphostin is a perylenequinone metabolite of the fungus Cladosporium cladosporoides that inhibits PKC with a Ki of 100 nmoVL after light activation.".32 This inhibitor appears to bind to the phorbol ester (diacylglycerol) recognition site of the enzyme, and is thus highly selective for PKC compared with other kinases.33 H-7 is I-(5-isoquinolinylsuIfonyl)-2-methylpyperazine and inhibits PKC with a Ki (half maximal inhibitory concentration) of 6 pmoI/L by binding to the catalytic domain.34 H-7 can also inhibit cyclic nucleotide-dependent protein kinases. However, a structural analog of H-7 termed HA 1004 (N-2 (guanidoethyl)-5-isoquinolinesulfonamide) is available which has a 20-fold lower Ki for inhibiting cyclic nucleotide-dependent kinases and myosin light chain kinase, but is a poor inhibitor of PKC. Thus, H-7 and HA1004 are a pair of inhibitors that can yield specific information about the involvement of PKC in a signal transduction pathway. Figure 5 shows an experiment in which TF-I cells were incubated with IL-3 alone or IL-3 plus either H-7, lightactivated calphostin, or HA1004 for 18 hours. The concentrations chosen were those shown to be optimal concentrations for inhibiting PKC in myeloid cells and other cultured mammalian ~e l l s .~' .~~ Both H-7 and light-activated calphostin were effective in reducing bcl-2 mRNA levels in cells cultured in the presence of IL-3 (Fig 5A) . It should be noted that in the HA 1004 lanes there is somewhat less GAPDH signal and this accounts for the small apparent decrease in bcl-2 mRNA in these lanes compared with control. After a densitometric scan of the gel and correction of bcl-2 mRNA levels against those of GAPDH, we found that HA1004 does not decrease bcl-2 levels at all, whereas H-7 and calphostin reduce the levels 100% and 60%, respectively. Although in the experiment shown calphostin C reduced bcl-2 levels by 60% and appeared to be somewhat less effective than H-7, in other experiments calphostin and H-7 were both equally capable of reducing bcl-2 mRNA to almost undetectable levels (data not shown and see Fig 5B) . To determine whether the PKC inhibitor-induced reduction in bcl-2 mRNA also resulted in a concomitant decrease in bcl-2 protein levels, we immunoblotted TF-l cellular proteins after incubation with IL-3 alone or IL-3 plus light-activated calphostin.
Figure 5B shows that after 8 hours of incubation with IL-3 in the presence of calphostin bcl-2 protein levels were significantly decreased, and by 16 hours in IL-3 plus calphostin bcl-2 protein levels were undetectable. Densitometric scanning of the immunoblot showed that by 8 hours the level of bcl-2 in the presence of IL-3 and calphostin was 35% of that in the presence of IL-3 alone. Similar experiments were 
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performed downregulating PKC with TPA. After 24 hours' incubation in IL-3 plus 100 nmol/L TPA bcl-2 protein levels were also undetectable (data not shown). Thus, biochemical inhibition of PKC activity or downregulation of the enzyme also results in a reduction in steady-state bcl-2 protein levels. The rapid decrease in bcl-2 levels in the inhibitor-treated cells could also indicate a shorter half-life for bcl-2 in apoptotic cells than has been reported p r e v i o~s l y .~~ As reported previously*" we found that these PKC inhibitors also induced apoptosis in TF-l cells (data not shown).
Inhibition of PKC inhibits the induction of bcl-2 mRNA in factor-deprived TF-l cells. Previous work has shown that GM-CSF or IL-3 can induce the c-jun immediate early response gene in cells that have been deprived of factor for 18 hours and this induction depends on PKC.I7.l8 This induction is probably occurring in the fraction of cells that have not entered apoptosis after the 18-hour deprivation. Therefore, we sought to determine whether in addition to maintaining bcl-2 gene expression, induction of bcl-2 gene expression through the L-3 receptor in factor-deprived cells also required PKC. Therefore, T F -I cells were deprived of IL-3 for 18 hours and then restimulated with IL-3 alone or with IL-3 plus either H-7 or HA 1004. Figure 6 shows that IL-3 alone induced the bcl-2 gene with a maximum induction at 4 hours after IL-3 addition. IL-3 deprivation had no significant effect on GAPDH levels. In contrast, if L-3 is added in the presence of H-7 no bcl-2 gene induction is observed. However, the cyclic nucleotide-dependent PK inhibitor, HA1004, did not inhibit hcl-2 induction by IL-3, but in fact appeared to enhance the IL-3 induction (Fig 6B) . Thus, both the induction and maintenance of bcl-2 gene expression by huIL-3 require active PKC.
This induction of bcl-2 mRNA is probably occurring in the 20% to 30% of the cells that have not entered apoptosis.
Actinomycin D and the IL-3 maintenance of bcl-2 mRNA levels. The steady-state level of mRNA is a balance between RNA transcription and degradation. To determine whether IL-3 regulation of bcl-2 mRNA levels in TF-1 cells required active transcription, TF-l cells were cultured in the presence of the transcription inhibitor actinomycin D and IL-3 for increasing periods of time. We found that within 4 hours of incubation of TF-l cells in the presence of IL-3 and actinomycin D there was a 65% decrease in bcl-2 mRNA levels (data not shown). No changes in the level of the longlived GAPDH mRNA were observed during this period. Thus, it is likely that bcl-2 mRNA is rapidly degraded in Hours After Stimulation TF-1 cells and requires continuous transcription to maintain mRNA levels.
DISCUSSION
It is clear from our study that withdrawal of IL-3 from human TF-I cells dramatically reduces both bcl-2 mRNA and protein expression. This decrease in bcl-2 expression accompanies the appearance of 200-bp multimers of DNA. This result is similar to what has been reported in IL-3-dependent murine FDCP-I cells in which IL-3 suppresses apoptosis and maintains bcl-2 gene expression.6I3 The bcl-2 protein is a 26-kD integral membrane protein that is localized at the outer mitochondrial membrane, endoplasmic, reticulum, and nuclear envelope.*-IO However, little information is available concerning the endogenous mechanism of bcl-2 regulation. We have shown in this study that relatively specific inhibitors of PKC interfere with the maintenance of bcl-2 gene expression through the human IL-3 receptor, whereas an inhibitor of cyclic nucleotide-dependent PKs did not alter bcl-2 mRNA levels. In addition, we have shown that upregulation of bcl-2 gene expression by huIL-3 in factordeprived TF-l cells is also blocked by inhibition of PKC. This upregulation is probably occurring in that fraction (20% to 30%) of the cells that have not irreversibly entered apoptosis. The fact that the L-3 reinduction of bcl-2 in the viable cells can be blocked by PKC inhibitors substantiates that the decrease of bcl-2 in cells growing in IL-3 in the presence of kinase inhibitor is caused by a block in signal transduction and is not secondary to apoptotic DNA degradation.
We have also found that downregulating PKC in these cells even in the presence of IL-3 dramatically reduced bcl-2 mRNA levels in these cells. Thus, either inhibition of PKC or downregulation of its levels interferes with L-3 maintenance of bcl-2 gene expression. Previous studies in huIL-3-dependent M07E cells also showed that the PKC inhibitor H-7 induced apoptosis in these cells but the cyclic nucleotide-dependent kinase inhibitor HA1004 did not influence apoptosis. We have observed that IL-3 cannot suppress apoptosis in TF-l cells in which PKC is downregulated or inhibited. Therefore, it is likely that maintenance of bcl-2 levels through PKC contributes to the suppression of apoptosis in these IL-3-dependent cells. Recently it has also been shown that PKC is not downstream of bcl-2 in suppressing apoptosis." This further supports our suggestion that PKC maintenance of bcl-2 expression may contribute to the suppression of apoptosis in these cells. The regulation of bcl-2 gene expression through this kinase may be relatively specific to huIL-3-dependent cells because downregulation of PKC does not reduce bcl-2 gene expression in HL-60 hematopoietic cells or in neuroblastoma cell^."^^^ However, the decrease in bcl-2 levels may not be the initiating event in the onset of apoptosis. PKC may also regulate the expression of other genes that may contribute to the inhibition of apoptosis. It will be important to determine if specific isozymes of PKC are involved in regulating bcl-2 gene expression. The epsilon and alpha isoforms should be of particular interest because they have been previously implicated in huIL-3/GM-CSF signal transduction.16."
Recent work by Ohtani et aI,l4 using 32 D cells transfected with the IL-2 receptor ,&chain, has shown that the tyrosine kinase inhibitor herbimycin A downregulated bcl-2 mRNA levels in cells growing in WEHI-3B cell-conditioned medium. Herbimycin A also inhibited the induction of bcl-2 mRNA in response to stimulation with IL-2 or IL-3 in factordeprived cells. However, overexpression of the bcl-2 protooncogene spared the cells from the induction of apoptosis induced by herbimycin A. Thus, these studies suggest that protein tyrosine kinases are part of a cascade upstream of bcl-2 gene expression. Our laboratory has previously shown that the rapid activation of a phosphatidylcholine-specific phospholipase C and PKC by the huIL-3 receptor are downstream of protein tyrosine phosphorylation in M07 cells or transfected NIH 3T3 cell^.'^^'^ This tyrosine phosphorylation is dependent on the recruitment of cytoplasmic tyrosine kinases to the IL-3 receptor &subunit because this protein does not contain any intrinsic tyrosine kinase a~tivity.~"~' Recent work from our laboratory has shown that the membrane proximal domain of the IL-3 receptor pc subunit strongly binds Src family kinases and weakly binds JAK-2 kinase:' Thus, we would suggest a signal transduction cascade for bcl-2 gene induction in which activation of such cytoplasmic tyrosine kinases through the L -3 receptor psubunit increases membrane diacylglycerol levels through activation of a phosphatidylcholine-specific phospholipase C. The increased diacylglycerol levels enhance the activity of specific PKC isoforms, and the ensuing cascade of serine/ threonine phosphorylations eventually results in the induction of bcl-2 gene expression. An important substrate for PKC phosphorylation is raf-l kinase. This kinase is activated and its serinelthreonine phosphorylation increased by IL- 3 .41. 42 It has recently been shown that raf-l kinase and bcl-2 can cooperate in suppressing apoptosis in murine IL-3-dependent cells." Thus, raf-l may be an important target in PKC regulation of apoptosis; however, in murine IL-3-dependent cells overexpression of raf-l does not increase endogenous bcl-2 gene expre~sion.4~ Our observation that a 65% decrease in bcl-2 mRNA levels within 4 hours of actinomycin D addition is consistent with the known halflife of 2.5 to 3.0 hours for the 8.5-kb and 5.5-kb mRNAs in lymphocytes.44 These lymphocyte studies also suggested that bcl-2 mRNA levels are regulated primarily at the level of transcription." Thus, it is likely that IL-3 is influencing bcl-2 mRNA levels at least partially at the transcriptional level in TF-1 cells.
Overexpression of the conventional and unconventional isoforms of PKC in IL-3-dependent 32D cells has not resulted in isolation of any factor-independent cell l i n e~.~~ In contrast, overexpression of tyrosine kinase oncogenes in IL-3-dependent cells is sufficient to produce factor-dependent cell lines.648 Thus, it is likely that the tyrosine kinase phosphorylation cascade induced by activation of the IL-3 receptor bifurcates into two arms. One leads to PKC activation and expression of bcl-2 and other genes that may play a role in cell survival without allowing cell proliferation. A second arm induces a cascade of phosphorylations resulting in the induction of other genes required for continued cell proliferation. This model would be consistent with the work of Nunez et a l , I 3 who showed that overexpression of the bcl-2 gene product in factor-dependent cells did not result in factor-independent clones, but allowed the transfected cells to survive for extended periods in the absence of factor. Thus, overexpression of PKC would be expected only to enhance cell survival and not to produce factor-independent cell lines. The activation of PKC by the IL-3 receptor may make an important contribution to the cell survival function of huIL-3.
